APA (7th ed.) Citation

LE, K., JR, S., MP, W., ML, H., T, S., A, G., . . . MA, W. (2024). Adaptation of an rVSV Ebola vaccine purification process for rapid development of a viral vaccine candidate for SARS-CoV-2. Biotechnology journal, 19(1), e2300041. https://doi.org/10.1002/biot.202300041

Chicago Style (17th ed.) Citation

LE, Kuczynski, Shallow JR, Watson MP, Homsy ML, Svab T, Gruber A, Rustandi RR, Hu J, and Winters MA. "Adaptation of an RVSV Ebola Vaccine Purification Process for Rapid Development of a Viral Vaccine Candidate for SARS-CoV-2." Biotechnology Journal 19, no. 1 (2024): e2300041. https://doi.org/10.1002/biot.202300041.

MLA (9th ed.) Citation

LE, Kuczynski, et al. "Adaptation of an RVSV Ebola Vaccine Purification Process for Rapid Development of a Viral Vaccine Candidate for SARS-CoV-2." Biotechnology Journal, vol. 19, no. 1, 2024, p. e2300041, https://doi.org/10.1002/biot.202300041.

Warning: These citations may not always be 100% accurate.